C07D 487/06
Peri-condensed systems
C07D487/06 (Peri-condensed systems) appears on 455 US grants and 483 published applications in this corpus.
Search patents in C07D- Granted patents
- 455
- Published applications
- 483
- Assignees
- 260
- Inventors
- 1,525
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 3 | 0 |
| 1978 | 5 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 5 | 0 |
| 1984 | 2 | 0 |
| 1985 | 5 | 0 |
| 1986 | 7 | 0 |
| 1987 | 4 | 0 |
| 1988 | 7 | 0 |
| 1989 | 5 | 0 |
| 1990 | 5 | 0 |
| 1991 | 8 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 10 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 1 |
| 2002 | 10 | 12 |
| 2003 | 5 | 15 |
| 2004 | 8 | 12 |
| 2005 | 11 | 13 |
| 2006 | 8 | 12 |
| 2007 | 11 | 13 |
| 2008 | 11 | 12 |
| 2009 | 6 | 13 |
| 2010 | 7 | 19 |
| 2011 | 7 | 9 |
| 2012 | 11 | 16 |
| 2013 | 10 | 19 |
| 2014 | 16 | 29 |
| 2015 | 21 | 32 |
| 2016 | 24 | 29 |
| 2017 | 26 | 15 |
| 2018 | 17 | 22 |
| 2019 | 25 | 25 |
| 2020 | 17 | 26 |
| 2021 | 12 | 14 |
| 2022 | 8 | 26 |
| 2023 | 16 | 22 |
| 2024 | 7 | 35 |
| 2025 | 14 | 27 |
| 2026 | 17 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fused cyclic compound as Wee-1 inhibitor, preparation method therefor and use thereof29 Sep 2026US 12,747,246 B2Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Materials for organic electroluminescent devices15 Sep 2026US 12,735,436 B2Universal Display Corporation
- System and methods for scalable melanin purification11 Aug 2026US 12,703,705 B1The United States of America as represented by the Secretary of the Army
- Indolo[3.2.1-jk]carbazole-6-carbonitrile derivatives as blue fluorescent emitters for use in OLEDS21 Jul 2026US 12,690,385 B2
- Amino acid- , peptide- and polypeptide-lipids, isomers, compositions, and uses thereof9 Jun 2026US 12,648,959 B2Massachusetts Institute of Technology
- Heterocyclic compounds as parp1 inhibitors1 Oct 2026US 2026/0297098 A1Synnovation Therapeutics, Inc.
- Heterocyclic compounds as parp1 inhibitors1 Oct 2026US 2026/0297102 A1Synnovation Therapeutics, Inc.
- Organic electroluminescent element and electronic device1 Oct 2026US 2026/0297107 A1Idemitsu Kosan Co., Ltd.
- Heterocyclic compounds as pi3ka inhibitors27 Aug 2026US 2026/0250251 A1Pikavation Therapeutics, Inc.
- Nitrogen-containing hetreocycles for organic electroluminescent devices27 Aug 2026US 2026/0255779 A1Merck Patent GmbH
Most cited
By later US patents
- Substituted heterocycle fused gamma-carbolines105US 7,071,186 B2Bristol-Myers Squibb Pharma Company · 2006
- Substituted heterocycle fused γ-carbolines103US 7,183,282 B2Bristol-Myers Squibb Pharma Company · 2007
- Protein kinase c. modulators. d.90US 5,145,842 AAlder Research Center Limited Partnership · 1992
- Antiviral therapeutic agents76US 7,994,139 B2BioCryst Pharmaceuticals, Inc. · 2011
- Multi-substituted fullerenes and methods for their preparation and characterization74US 6,162,926 ASphere Biosystems, Inc. · 2000